Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
92,448,158
-
Total 13F shares
-
9,017,971
-
Share change
-
+201,445
-
Total reported value
-
$104,753,394
-
Price per share
-
$11.62
-
Number of holders
-
40
-
Value change
-
+$2,569,853
-
Number of buys
-
22
-
Number of sells
-
8
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q2 2019
As of 30 Jun 2019,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,017,971 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Fosun International Ltd, BlackRock Inc., FMR LLC, KORNITZER CAPITAL MANAGEMENT INC /KS, VANGUARD GROUP INC, STATE STREET CORP, Point72 Asset Management, L.P., and Asymmetry Capital Management, L.P..
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.